|
시장보고서
상품코드
2077615
알레르기성 천식 치료제 시장 : 약제 종류별, 투여 경로별, 지역별Allergic Asthma Therapeutics Market, By Drug Type, By Route of Administration, and By Region |
||||||
알레르기성 천식 치료제 시장은 2026년에 79억 5,000만 달러 규모에 달할 것으로 추정되며, 2033년까지 99억 1,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 3.2%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 79억 5,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 3.20% | 2033년 시장 규모 예측: | 99억 1,000만 달러 |
알레르기성 천식(알레르기 유발성 천식이라고도 함)은 만성 염증성 질환입니다. 알레르기성 천식은 알레르겐을 흡입했을 때 기도가 수축되는 호흡기질환입니다. 알레르기성 천식이란, 알레르겐을 흡입함으로써 호흡 곤란이 발생하는 상태를 말합니다. 이는 알레르기 반응의 일환으로 기도가 부어오르면서 발생합니다. 일반적인 알레르기 유발 물질로는 꽃가루, 반려동물의 비듬, 곰팡이 포자 등이 있습니다. 이러한 유형의 천식은 소아와 성인 모두에게 매우 흔하게 나타납니다. 알레르기성 천식의 증상으로는 숨가쁨, 기침, 천명음, 코막힘, 눈 가려움, 발진 등이 있습니다. 천식은 환경적 및 유전적 요인에 의해 유발되는 기도 염증과 협착을 특징으로 하는, 장기간 지속되는 염증성 폐 질환입니다. 대기 오염, 에어로졸 형태의 세정제, 담배 연기, 장작 연소, 강한 냄새 등의 자극 물질은 알레르기 반응을 일으키지 않습니다. 그러나 이러한 것들은 기도를 자극하여 천식 증상을 악화시킬 가능성이 있습니다. 천식 발작은 기도 주변 근육이 수축하는 것(기관지 수축)을 특징으로 하며, 이로 인해 기도가 좁아져 호흡이 어려워집니다. 호흡기질환 발생률의 증가와 주요 기업들의 전략적인 사업 확장이 예측 기간 동안 전 세계 알레르기성 천식 치료제 시장의 성장을 견인할 것으로 예상됩니다.
시장 역학
호흡기질환 유병률의 증가와 비용 대비 효과가 높은 치료법에 대한 수요 증가가 예측 기간 동안 전 세계 알레르기성 천식 치료제 시장의 성장을 견인할 것으로 예상됩니다. 또한, 대기 오염 수준의 악화와 만성 폐쇄성 폐질환(COPD) 환자 수의 급증 역시 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 예를 들어, 2023년 3월 16일 세계보건기구(WHO)에 따르면, 만성 폐쇄성 폐질환(COPD)은 전 세계 사망 원인 중 3위를 차지하며, 2020년에는 323만 명이 이로 인해 사망했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 알레르기성 천식 치료제 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 세계 알레르기성 천식 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 알레르기성 천식 치료제 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 알레르기성 천식 치료제 시장 : 약물 유형별, 2021-2033년
제5장 세계의 알레르기성 천식 치료제 시장 : 투여 경로별, 2021-2033년
제6장 세계의 알레르기성 천식 치료제 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSM 26.07.08Allergic Asthma Therapeutics Market is estimated to be valued at USD 7.95 Bn in 2026 and is expected to reach USD 9.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.20% | 2033 Value Projection: | USD 9.91 Bn |
Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficulties from inhaling allergens. It occurs when the airways swell as part of an allergic reaction. Common allergens include pollen, dander and mold spores. This type of asthma is very common in both children and adults. Symptoms of allergic asthma can include shortness of breath, coughing, wheezing, stuffy nose, itchy eyes and a rash. Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Irritants such as air pollution, aerosol cleaning products, tobacco smoke, wood fires, and strong odors don't cause an allergic reaction. But they may inflame your airways and make asthma symptoms worse. An asthma attack is characterized by tightening of the muscles around the airways (bronchoconstriction), which narrows the airway and makes breathing difficult. The rising incidence of respiratory diseases and the strategic expansions by the key players are expected to propel the growth of global allergic asthma therapeutics market over the forecast period.
Market Dynamics
The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the global allergic asthma therapeutics market growth over the forecast period. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. For instance, on March 16, 2023, according to the World Health Organization (WHO), Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2020.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global allergic asthma therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are ASLAN Pharmaceuticals, Takeda Pharmaceutical Company Limited, CHIESI Farmaceutici S.p.A., CSL, NIOX, Fountain Therapeutics, Eli Lilly and Company, GSK plc., Infinity Pharmaceuticals, Inc., Mabtech, Kineta Inc., Marinomed Biotech AG, Mycenax Biotech Inc., AstraZeneca, and Panacea Biotec.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global allergic asthma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic asthma therapeutics market
Detailed Segmentation:
- Global Allergic Asthma Therapeutics Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Corticosteroids
- Bronchodilators
- Leukotriene modifiers
- Immunotherapy
- Biologics
- Others
- Global Allergic Asthma Therapeutics Market By Route of Administration:
- Oral
- Inhaled
- Others
- Global Allergic Asthma Therapeutics Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- ASLAN Pharmaceuticals *
- Takeda Pharmaceutical Company Limited
- CHIESI Farmaceutici S.p.A.
- CSL
- NIOX
- Fountain Therapeutics
- Eli Lilly and Company
- GSK plc.
- Infinity Pharmaceuticals, Inc.
- Mabtech
- Kineta Inc.
- Marinomed Biotech AG
- Mycenax Biotech, Inc.
- AstraZeneca
- Panacea Biotec
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER's Analysis
4. Global Allergic Asthma Therapeutics Market, By Drug Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Leukotriene modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
5. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segments Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Inhaled
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
6. Global Allergic Asthma Therapeutics Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- ASLAN Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CHIESI Farmaceutici S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CSL
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NIOX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fountain Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Infinity Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mabtech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kineta Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Marinomed Biotech AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mycenax Biotech Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Panacea Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
